Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate R Rajan, MK Sabnani, V Mavinkurve, H Shmeeda, H Mansouri, ... Journal of Controlled Release 271, 139-148, 2018 | 70 | 2018 |
Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses MK Sabnani, R Rajan, B Rowland, V Mavinkurve, LM Wood, AA Gabizon, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 259-262, 2015 | 60 | 2015 |
Melanoma peptide MHC specific TCR expressing T-Cell membrane camouflaged PLGA nanoparticles for treatment of melanoma skin cancer S Yaman, H Ramachandramoorthy, G Oter, D Zhukova, T Nguyen, ... Frontiers in bioengineering and biotechnology 8, 943, 2020 | 52 | 2020 |
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through# INPST hashtag analysis RK Singla, R De, T Efferth, B Mezzetti, MS Uddin, F Ntie-Kang, D Wang, ... Phytomedicine 108, 154520, 2023 | 32 | 2023 |
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets DB Lowe, CK Bivens, AS Mobley, CE Herrera, AL McCormick, T Wichner, ... MAbs 9 (4), 603-614, 2017 | 29 | 2017 |
Detection of specific antibody-ligand interactions with a self-induced back-action actuated nanopore electrophoresis sensor SSS Peri, MK Sabnani, MU Raza, S Ghaffari, S Gimlin, DD Wawro, JS Lee, ... Nanotechnology 31 (8), 085502, 2019 | 25 | 2019 |
Quantifying autophagosomes and autolysosomes in cells using imaging flow cytometry R Rajan, M Karbowniczek, HR Pugsley, MK Sabnani, A Astrinidis, ... Cytometry Part A 87 (5), 451-458, 2015 | 21 | 2015 |
Quantification of low affinity binding interactions between natural killer cell inhibitory receptors and targeting ligands with a self-induced back-action actuated nanopore … SSS Peri, MK Sabnani, MU Raza, EL Urquhart, S Ghaffari, JS Lee, ... Nanotechnology 32 (4), 045501, 2020 | 20 | 2020 |
Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles KTN Serkan Yaman a c 1, Harish Ramachandramoorthy a c 1, Priyanka Iyer a ... Bioactive Materials 34, Pages 422-435, 2024 | 8 | 2024 |
Identification and characterization of proteases and amylases producing bacillus licheniformis strain EMBS026 by 16S rRNA gene sequencing NS Anuraj, MK Sabnani, M Yadav, K Jyotsana, S Deepika, C Rachna, ... International Journal of Microbiology Research 4 (5), 231, 2012 | 8 | 2012 |
Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity MEA Zaki, SA Al-Hussain, VH Masand, MK Sabnani, A Samad International Journal of Molecular Sciences 22 (15), 8352, 2021 | 5 | 2021 |
TCR-like antibody duocarmycin conjugates promote cytotoxicity of tumor cells expressing low peptide/HLA targets CE Herrera, DB Lowe, CK Bivens, AS Mobley, A McCormick, T Wichner, ... The Journal of Immunology 198 (1_Supplement), 120.4-120.4, 2017 | 4 | 2017 |
Quantification of low-affinity kinetics between cancer immunity relevant ligands and natural killer cell receptors with a self-induced back-action actuated nanopore … G Alexandrakis, SSS Peri, MK Subnani, UM Raza, S Ghaffari, JS Lee, ... Optical Trapping and Optical Micromanipulation XVII 11463, 1146306, 2020 | 2 | 2020 |
Self-induced back-action actuated Nanopore electrophoresis (SANE) sensor for label-free detection of cancer immunotherapy-relevant antibody-ligand interactions SSS Peri, MU Raza, MK Sabnani, S Ghaffari, S Gimlin, DD Wawro, JS Lee, ... Biomedical Engineering Technologies: Volume 2, 343-376, 2022 | 1 | 2022 |
Pegylated liposomal alendronate: The impact of the drug cargo on carrier-induced immune modulation R Rajan, MK Sabnani, LM Wood, V Mavinkurve, AA Gabizon, NM La-Beck Cancer Research 76 (14_Supplement), 4008-4008, 2016 | 1 | 2016 |
Double sided chimeric antigen receptor (car) engineered cell membrane based drug delivery systems K Nguyen, J Weidanz, S Yaman, H Ramachandramoorthy, MK Sabnani US Patent App. 18/558,882, 2024 | | 2024 |
A novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models RR Kowash, M Sabnani, LT Gray, Q Deng, L Girard, Y Naito, K Masahiro, ... bioRxiv, 2024.07. 30.605880, 2024 | | 2024 |
Early‐Life Thymectomy Results in T‐Cell Aging and Arterial Dysfunction in Middle‐Aged Mice DJ Buckley, S Sharma, M Sabnani, PJ Fadel, DW Trott The FASEB Journal 36, 2022 | | 2022 |
Peripheral Blood Mononuclear Cell‐Derived Superoxide Production, Spontaneous Baroreflex Sensitivity, and Vascular Function in Chronic Kidney Disease Patients J Kaur, MK Sabnani, BY Stephens, D Nandadeva, JA Weidanz, PJ Fadel The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
QUANTIFICATION OF LOW AFFINITY KINETICS BETWEEN Qa-1b Qdm LIGANDS AND NK INHIBITORY RECEPTORS CD94/NKG2A WITH A SELF-INDUCED BACK-ACTION ACTUATED NANOPORE ELECTROPHORESIS (SANE … SSS Peri, MK Sabnani, MU Raza, S Ghaffari, JS Lee, MJ Kim, J Weidanz, ... SELF-INDUCED BACK ACTION ACTUATED NANOPORE ELECTROPHORESIS (SANE) SENSOR FOR …, 2019 | | 2019 |